Tempo Therapeutics, Inc
Tempo Therapeutics, Inc is a small business in San Diego, CA registered on SAM.gov to bid on federal contracts. It has won 5 small business R&D awards worth $5.6 million through the SBIR and STTR programs since 2016, according to SBIR.gov.
- UEI
- EA4HW67GFBS1
- CAGE code
- 799L6
- SAM.gov registration
- Active
Registration details
From SAM.gov's monthly public file dated Oct 5, 2026. If the business has updated its registration since, SAM.gov shows the newer details.
| Legal business name | Tempo Therapeutics, Inc |
|---|---|
| Unique Entity ID (UEI) | EA4HW67GFBS1 |
| CAGE code | 799L6 |
| Location | San Diego, CA |
| SAM.gov registration | Active through Aug 26, 2027 |
| Business started | 2014 |
| Primary NAICS code | 541714: Research and Development in Biotechnology (except Nanobiotechnology) |
| Website | www.tempothera.com |
Certifications and business types
SAM.gov's public file from Oct 5, 2026 lists no SBA certification (8(a), HUBZone or WOSB) for Tempo Therapeutics, Inc. The file sometimes leaves a certification out, and a newer one won't be in it yet: SBA's certification search and the firm's SAM.gov entry have the current list. SBA certifications let a business compete for set-aside contracts. See set-aside contracts explained.
SBIR and STTR awards
Tempo Therapeutics, Inc has won 5 small business R&D awards worth $5.6 million through the SBIR and STTR programs since 2016, 3 of them Phase II and 1 STTR. Funded by NIH and NSF.
| Awarded | Agency | Project | Amount |
|---|---|---|---|
| Jun 15, 2023 | NSF | STTR Phase II STTR Phase II:VaxMAP a single dose multivalent vaccine to produce durable and cross-reactive… | $1 million |
| Sep 15, 2021 | NIH | SBIR Phase II A first in human clinical study of TT101, a synthetic immunomodulatory material to build new… | $2.5 million |
| Sep 1, 2020 | NSF | SBIR Phase I SBIR Phase I: A new vaccine technology to engineer a potent and polarized immunity against COVID-19 | $255,998 |
| Sep 15, 2019 | NIH | SBIR Phase II MAP: a Flowable, Precision-Engineered, and Tunable Tissue Scaffold Leveraging Hyper-Porous… | $1.6 million |
| Sep 16, 2016 | NIH | SBIR Phase I A flowable microporous biomaterial as a low cost, high efficacy diabetic chronic ulcer treatment | $224,999 |
Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.
Federal contract history
USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.
NAICS codes Tempo Therapeutics, Inc is small under
On its SAM.gov registration, Tempo Therapeutics, Inc meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Open contracts in Tempo Therapeutics, Inc's NAICS codes
27 open federal opportunities on SAM.gov use one of Tempo Therapeutics, Inc's NAICS codes and are open to it: no set-aside, or, in the code it is registered small under, a small business set-aside or one for a certification it holds. Here are a few, those in its primary code first (none of these are in California right now), then the soonest due.
- UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Event or sign-up Oct 14, 2026
- Protein ENGineering (PENG)
✦ DARPA's Defense Sciences Office wants teams to build a platform that can edit existing (endogenous) proteins inside living cells, without permanently changing DNA. It is a…
Due in 7 daysOct 19, 2026
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
✦ NIH (NIDA) is running a sources sought notice, not a solicitation, to find companies that can run, consolidate or recompete NIH biorepositories for FY 2028.
Due in 8 daysOct 20, 2026
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
✦ NIH (through NIDA) is asking small businesses whether they can run one or more NIH biorepositories (sample banks) for FY 2028, including the NIDA Center for Genetic Studies and…
Due in 8 daysOct 20, 2026
- NAWCWD Broad Agency Announcement
Due in 18 daysOct 30, 2026
Similar small businesses
Other small businesses of a similar size with the same primary NAICS code (541714) that have won federal contracts in California:
- Doubleshot Inc, Santa Rosa, CA
- Dalton Bioanalytics Inc., Los Angeles, CA
- Quick Biology Inc, Monrovia, CA
- Synthego Holdings LLC, Redwood City, CA
- Ultima Genomics, Inc., Fremont, CA
- Tippingpoint Biosciences, Inc., Los Altos, CA
Frequently asked questions
What is Tempo Therapeutics, Inc's CAGE code?
Tempo Therapeutics, Inc's CAGE code is 799L6. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.
What is Tempo Therapeutics, Inc's UEI?
Tempo Therapeutics, Inc's Unique Entity ID (UEI) is EA4HW67GFBS1. SAM.gov assigns the UEI, and it identifies the business across the federal government.
Is Tempo Therapeutics, Inc's SAM.gov registration active?
Yes, as of SAM.gov's public data from Oct 5, 2026, Tempo Therapeutics, Inc's registration is active through Aug 26, 2027. Registrations are renewed every year.
Is Tempo Therapeutics, Inc a small business?
Tempo Therapeutics, Inc is registered on SAM.gov as small under 1 NAICS code, including its primary code, 541714. Size is set per NAICS code, so a business can be small for some contracts and not others.
Keep going
- Look up another business's CAGE code or UEI
- Check a SAM.gov registration's status
- How to become a government subcontractor
Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To report a mistake on this page, or to ask us to remove it, email hello@fedready.us with the page address; we reply within 2 business days. For a removal, write from an address at the company.